Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Point-of-care testing: an introduction.

Sheryl L Gutierres1, Timothy E Welty

  • 1College of Pharmacy, Department of Clinical and Administrative Sciences, The University of Oklahoma, Tulsa, OK 74135, USA. sheryl-gutierres@ouhsc.edu

The Annals of Pharmacotherapy
|January 27, 2004
PubMed
Summary

Point-of-care testing (POCT) can improve patient outcomes and reduce healthcare costs when integrated with healthcare delivery changes. Pharmacists utilize POCT in patient care programs, but must navigate regulatory considerations.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

American Epilepsy Society/International League Against Epilepsy-North America Joint Task Force for Epilepsy Health Care Disparities in the United States.

Epilepsy currents·2025
Same author

The Fundamentals of Antiseizure Medications: A Through Z.

Epilepsy currents·2024
Same author

Recommendations for treatment strategies in people with epilepsy during times of shortage of antiseizure medications

Epileptic disorders : international epilepsy journal with videotape·2022
Same author

Suboptimal Dosing of Benzodiazepines and Levetiracetam in a Cohort of Status Epilepticus Patients and Outcomes Associated with Inadequate Dosing.

Journal of pharmacy practice·2022
Same author

Barriers to generic antiseizure medication use: Results of a global survey by the International League Against Epilepsy Generic Substitution Task Force.

Epilepsia open·2022
Same author

FDA safety warning on the cardiac effects of lamotrigine: An advisory from the Ad Hoc ILAE/AES Task Force.

Epilepsia open·2021

Area of Science:

  • Health Services Research
  • Clinical Diagnostics

Background:

  • Point-of-care testing (POCT) is increasingly integrated into patient care and therapeutic decision-making.
  • The adoption of POCT necessitates changes in healthcare delivery systems for optimal impact.

Purpose of the Study:

  • To review literature on point-of-care testing (POCT).
  • To assess the impact of POCT on patient treatment outcomes and healthcare costs.
  • To examine the role of POCT in pharmaceutical care delivery.

Main Methods:

  • Literature search of MEDLINE (PubMed) from 1965-2003 using keywords: point-of-care testing, near patient testing, pharmaceutical care, pharmacists, outcomes, and economics.
  • Inclusion of comparative studies, demonstration project reports, systematic reviews, government documents, legislation, and regulations.

Related Experiment Videos

  • Emphasis on comparative studies and demonstration project reports for data synthesis.

    • Main Results:

    • No studies isolated the impact of POCT alone; all incorporated it with delivery system changes, showing significant improvements.
    • While POCT costs exceed traditional lab testing, potential cost offsets exist through improved patient care management, outcomes, and reduced healthcare system utilization.
    • Pharmacists have successfully employed POCT in disease management, subject to government regulations.

    Conclusions:

    • Limited evidence suggests POCT, combined with healthcare delivery system modifications, may enhance patient outcomes and lower healthcare expenditures.
    • Pharmacists' use of POCT in patient care programs is effective but requires careful attention to governing regulations and laws.
    • Further research is essential to fully understand the role and impact of POCT in patient care.